EXACT SCIENCES CORP (EXAS) EBT (2010 - 2025)

Exact Sciences (EXAS) has reported EBT for 16 consecutive years, with -$85.1 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, EBT rose 90.29% year-over-year to -$85.1 million in Q4 2025; TTM through Dec 2025 was -$203.9 million, a 80.32% increase from a year earlier, with the FY2025 full-year figure at -$203.9 million, up 80.32% from the prior year.
• EBT was -$85.1 million for Q4 2025 at Exact Sciences, down from -$17.8 million in the prior quarter.
• Over five years, EBT peaked at $1.0 million in Q3 2023 and troughed at -$876.0 million in Q4 2024.
• A 5-year average of -$145.8 million and a median of -$104.7 million in 2024 frame the typical range for EBT.
• Across the five-year window, EBT surged 100.69% in 2023 and sank 3688.49% in 2024, its largest moves.
• Over 5 years, EBT stood at -$224.9 million in 2021, then jumped by 42.22% to -$129.9 million in 2022, then soared by 61.23% to -$50.4 million in 2023, then slumped by 1638.86% to -$876.0 million in 2024, then surged by 90.29% to -$85.1 million in 2025.
• The last three EBT figures came in at -$85.1 million (Q4 2025), -$17.8 million (Q3 2025), and -$57000.0 (Q2 2025), per Business Quant data.